Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by RelevantStockon Feb 19, 2021 12:41pm
90 Views
Post# 32610575

RE:RE:RE:How about you manipulate the market a little more Lith

RE:RE:RE:How about you manipulate the market a little more LithThis is very easy to see:

- Colonsentry was an unusual product at the time, with Grail and Exact Sciences now liquid biopsy is the gold standard to achieve in disease screening

- Telehealth is the future, here again this has become a consensus

- Stagezero has been working for more than a decade on a mRNA product, the top biotechnology that is saving the universe now

- Tripp was one the first person to dare to say that COVID testing would be with us at least until 2021, early in the pandemic.  Everything he has done or planned since that time was spot on (highly-reliable tests, we will increase our client base gradually for testing, airlines partnerships on the horizon, etc etc)

- The company is making money, a lot and they doubled in size during the last year

frewil11 wrote: The big worry is basically what did they not do that Colonsentry was a big bust , what is going to be different this time ?


<< Previous
Bullboard Posts
Next >>